Because of experimental evidence that the tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) induces apoptosis in liver cancer cells but not in healthy hepatocytes, this molecule was suggested to have potential as a promising alternative or additive therapeutic tool for HCC 14. This evidence concerns the gene TNFSF10 and liver cancer.